Hawk70 mate you are confused
Phase 1 clinical trial - Indication Stroke and cardioprotection, phase 1 trial will be completed by Scientia Clinical Research, Ethics approval expected this week. Fully funded as per raise and submission of IND and also further indications coming up strengthening drug IP. Don’t post again after this. Also bought more on Friday because again a 60 billion dollar market unmet, drug gone through 6 years of preclinical setting and now safety in humans about to be ticked off going to become north of a 100 million market cap and will become a billion dollar plus market cap over next 24 months. Keep telling me to sell my shares mate and again I buy more
TBI indication is with Walter Reed as per CEO interviews and that will be seperate indication and funded via non dilutive means. Fact
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.18M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.0¢ | $114.5K | 576.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 78460 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 60000 | 2 |
View Market Depth
| Last trade - 15.59pm 16/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |